Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1988 Sep;51(9):1215–1218. doi: 10.1136/jnnp.51.9.1215

Borrelia burgdorferi antibodies in patients with relapsing/remitting form and chronic progressive form of multiple sclerosis.

E Schmutzhard 1, P Pohl 1, G Stanek 1
PMCID: PMC1033030  PMID: 3225603

Abstract

Sera of 106 multiple sclerosis patients and 103 closely matched controls were examined for Borrelia burgdorferi antibodies. The prevalence rate in multiple sclerosis patients was 14.2%, in controls 25.2%. Overall prevalence was 20.1%. Mean IgG antibody level was insignificantly higher in controls than in multiple sclerosis patients. Patients with a chronic progressive course of multiple sclerosis had an insignificantly higher mean borrelia antibody level, when compared with those suffering from relapsing/remitting form of disease.

Full text

PDF
1217

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ackermann R., Gollmer E., Rehse-Küpper B. Progressive Borrelien-Enzephalomyelitis. Chronische Manifestation der Erythema-chronicum-migrans-Krankheit am Nervensystem. Dtsch Med Wochenschr. 1985 Jun 28;110(26):1039–1042. doi: 10.1055/s-2008-1068956. [DOI] [PubMed] [Google Scholar]
  2. Baumhackl U., Kristoferitsch W., Sluga E., Stanek G. Neurological manifestations of Borrelia burgdorferi-infections: the enlarging clinical spectrum. Zentralbl Bakteriol Mikrobiol Hyg A. 1987 Feb;263(3):334–336. doi: 10.1016/s0176-6724(87)80087-1. [DOI] [PubMed] [Google Scholar]
  3. Bendig J. W., Ogilvie D. Severe encephalopathy associated with Lyme disease. Lancet. 1987 Mar 21;1(8534):681–682. doi: 10.1016/s0140-6736(87)90440-5. [DOI] [PubMed] [Google Scholar]
  4. Benoit P., Dournon E., Destee A., Warot P. Spirochaetes and Lyme disease. Lancet. 1986 Nov 22;2(8517):1223–1223. doi: 10.1016/s0140-6736(86)92236-1. [DOI] [PubMed] [Google Scholar]
  5. Fumarola D. Multiple sclerosis and Borrelia burgdorferi. Lancet. 1986 Sep 6;2(8506):575–575. doi: 10.1016/s0140-6736(86)90142-x. [DOI] [PubMed] [Google Scholar]
  6. Gay D., Dick G. Is multiple sclerosis caused by an oral spirochaete? Lancet. 1986 Jul 12;2(8498):75–77. doi: 10.1016/s0140-6736(86)91611-9. [DOI] [PubMed] [Google Scholar]
  7. Gay D., Dick G. Spirochaetes, Lyme disease, and multiple sclerosis. Lancet. 1986 Sep 20;2(8508):685–685. doi: 10.1016/s0140-6736(86)90189-3. [DOI] [PubMed] [Google Scholar]
  8. Klöter I., Adam T., Schabet M., Wiethölter H., Peiffer J. Borrelia-induced meningoradiculitis--two different forms of the disease. Eur Neurol. 1986;25(4):262–268. doi: 10.1159/000116019. [DOI] [PubMed] [Google Scholar]
  9. Kohler J., Kasper J., Kern U., Thoden U., Rehse-Küpper B. Borrelia encephalomyelitis. Lancet. 1986 Jul 5;2(8497):35–35. doi: 10.1016/s0140-6736(86)92574-2. [DOI] [PubMed] [Google Scholar]
  10. Kohlhepp W., Mertens H. G., Oschmann P. Acute and chronic illness after tick-bite Borrelia burgdorferi-infections: results of treatment. Zentralbl Bakteriol Mikrobiol Hyg A. 1987 Feb;263(3):365–371. doi: 10.1016/s0176-6724(87)80094-9. [DOI] [PubMed] [Google Scholar]
  11. Kristoferitsch W., Steck A. J., Murray N., Stanek G., Lanschützer H. Oligoclonal antibodies in CSF of patients with meningopolyneuritis Garin-Bujadoux-Bannwarth: Ig class, light chain type and specificity. Zentralbl Bakteriol Mikrobiol Hyg A. 1987 Feb;263(3):307–313. doi: 10.1016/s0176-6724(87)80082-2. [DOI] [PubMed] [Google Scholar]
  12. Muhlemann M. F., Wright D. J. Emerging pattern of Lyme disease in the United Kingdom and Irish Republic. Lancet. 1987 Jan 31;1(8527):260–262. doi: 10.1016/s0140-6736(87)90074-2. [DOI] [PubMed] [Google Scholar]
  13. Münchhoff P., Wilske B., Preac-Mursic V., Schierz G. Antibodies against Borrelia burgdorferi in Bavarian forest workers. Zentralbl Bakteriol Mikrobiol Hyg A. 1987 Feb;263(3):412–419. doi: 10.1016/s0176-6724(87)80101-3. [DOI] [PubMed] [Google Scholar]
  14. Pachner A. R., Steere A. C. CNS manifestations of third stage Lyme disease. Zentralbl Bakteriol Mikrobiol Hyg A. 1987 Feb;263(3):301–306. doi: 10.1016/s0176-6724(87)80081-0. [DOI] [PubMed] [Google Scholar]
  15. Pachner A. R., Steere A. C. The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis. Neurology. 1985 Jan;35(1):47–53. doi: 10.1212/wnl.35.1.47. [DOI] [PubMed] [Google Scholar]
  16. Paul H., Gerth H. J., Ackermann R. Infectiousness for humans of Ixodes ricinus containing Borrelia burgdorferi. Zentralbl Bakteriol Mikrobiol Hyg A. 1987 Feb;263(3):473–476. doi: 10.1016/s0176-6724(87)80113-x. [DOI] [PubMed] [Google Scholar]
  17. Pfister H. W., Einhäupl K. M., Wilske B., Preac-Mursic V. Bannwarth's syndrome and the enlarged neurological spectrum of arthropod-borne borreliosis. Zentralbl Bakteriol Mikrobiol Hyg A. 1987 Feb;263(3):343–347. doi: 10.1016/s0176-6724(87)80089-5. [DOI] [PubMed] [Google Scholar]
  18. Poser C. M., Paty D. W., Scheinberg L., McDonald W. I., Davis F. A., Ebers G. C., Johnson K. P., Sibley W. A., Silberberg D. H., Tourtellotte W. W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983 Mar;13(3):227–231. doi: 10.1002/ana.410130302. [DOI] [PubMed] [Google Scholar]
  19. Reik L., Jr, Smith L., Khan A., Nelson W. Demyelinating encephalopathy in Lyme disease. Neurology. 1985 Feb;35(2):267–269. doi: 10.1212/wnl.35.2.267. [DOI] [PubMed] [Google Scholar]
  20. Rose A. S., Ellison G. W., Myers L. W., Tourtellotte W. W. Criteria for the clinical diagnosis of multiple sclerosis. Neurology. 1976 Jun;26(6 Pt 2):20–22. doi: 10.1212/wnl.26.6_part_2.20. [DOI] [PubMed] [Google Scholar]
  21. Rousseau J. J., Lust C., Zangerle P. F., Bigaignon G. Acute transverse myelitis as presenting neurological feature of Lyme disease. Lancet. 1986 Nov 22;2(8517):1222–1223. doi: 10.1016/s0140-6736(86)92235-x. [DOI] [PubMed] [Google Scholar]
  22. Schmutzhard E., Pohl P., Stanek G. Lyme borreliosis and multiple sclerosis. Lancet. 1987 Jan 17;1(8525):167–168. doi: 10.1016/s0140-6736(87)92009-5. [DOI] [PubMed] [Google Scholar]
  23. Steere A. C., Bartenhagen N. H., Craft J. E., Hutchinson G. J., Newman J. H., Pachner A. R., Rahn D. W., Sigal L. H., Taylor E., Malawista S. E. Clinical manifestations of Lyme disease. Zentralbl Bakteriol Mikrobiol Hyg A. 1986 Dec;263(1-2):201–205. doi: 10.1016/s0176-6724(86)80123-7. [DOI] [PubMed] [Google Scholar]
  24. Stiernstedt G., Sköldenberg B., Gårde A., Kolmodin G., Jörbeck H., Svenungsson B., Carlström A. Clinical manifestations of Borrelia infections of the nervous system. Zentralbl Bakteriol Mikrobiol Hyg A. 1987 Feb;263(3):289–296. doi: 10.1016/s0176-6724(87)80079-2. [DOI] [PubMed] [Google Scholar]
  25. Weder B., Wiedersheim P., Matter L., Steck A., Otto F. Chronic progressive neurological involvement in Borrelia burgdorferi infection. J Neurol. 1987 Jan;234(1):40–43. doi: 10.1007/BF00314008. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES